Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolving problems with resistant pathogens.

J Chastre1

  • 1Université Paris 6 Pierre et Marie Curie, Service de Reanimation Medicale, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France. jean.chastre@psl.ap-hop-paris.fr

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|May 3, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective.

Medicina intensiva·2016
Same author

Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same author

Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
Same journal

Impact of low-dose chest CT and multiplex PCR on antibiotic usage for community-acquired pneumonia: multicentre prospective controlled before-after study with cluster randomisation (CAP-NEXT study).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Oral metronidazole versus clindamycin to treat bacterial vaginosis in pregnancies at risk for preterm labor.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Efficacy and safety of a radiographic severity-stratified all-oral short treatment regimen for multidrug/rifampicin-resistant tuberculosis in China: An open-label, multi-center,randomized controlled, non-inferiority trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Impact of generic market entry on the consumption of last-resort antibiotics in six European countries.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same journal

Added value of point-of-care testing for Group A Streptococcus in community pharmacy sore throat pathways: Analysis of the Wales Sore Throat Test and Treat service.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
See all related articles

Antimicrobial resistance is increasing, especially in intensive care units (ICUs), due to pathogens like methicillin-resistant Staphylococcus aureus (MRSA). Effective management requires careful antibiotic use and selection to combat resistant infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Critical Care Medicine

Background:

  • Antimicrobial resistance patterns have shifted significantly over the last decade.
  • Increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative bacterial resistance are key concerns.
  • Intensive care units (ICUs) are hotspots for the emergence and spread of antimicrobial-resistant pathogens due to patient vulnerability and high antimicrobial exposure.

Purpose of the Study:

  • To highlight the changing landscape of antimicrobial resistance.
  • To emphasize the critical role of ICUs in the proliferation of resistant pathogens.
  • To underscore the need for judicious antimicrobial stewardship.

Main Methods:

  • Observational analysis of resistance trends.

Related Experiment Videos

  • Review of pathogen prevalence in healthcare settings.
  • Assessment of factors contributing to antimicrobial resistance in ICUs.

    • Main Results:

    • Significant increases in resistance rates for various pathogens, particularly in ICU settings.
    • MRSA strains, including those with Panton-Valentine leukocidin (PVL) genes, are a growing concern.
    • Resistance rates are consistently higher in ICUs compared to non-ICU patient populations.

    Conclusions:

    • Antimicrobial resistance poses a major challenge, amplified within ICUs.
    • Prudent antimicrobial use, including appropriate selection, dosing, and duration, is essential for managing resistant infections.
    • Combating antimicrobial resistance requires a multi-faceted approach focusing on stewardship and infection control.